Hisamitsu Pharmaceutical
(OTC) HTSUF
This security has been delisted. This page is retained for historical reference.
HTSUF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowHTSUF Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
11%
Net Income Margin
12%
Return on Equity
7%
Return on Capital
6%
Return on Assets
5%
Earnings Yield
N/A
Dividend Yield
1.99%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$96.40B
Operating Income
$17.97B
EBITDA
$25.04B
Operating Cash Flow
$17.53B
Capital Expenditure
$8.02B
Free Cash Flow
$9.51B
Cash & ST Invst.
$118.98B
Total Debt
$2.38B
Hisamitsu Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$48.65B
+8.7%
Gross Profit
$26.96B
+8.7%
Gross Margin
55.42%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,759
N/A
Net Income
$7.29B
-10.0%
EBITDA
$7.14B
-1.6%
Quarterly Fundamentals
Net Cash
$116.60B
-6.9%
Accounts Receivable
$56.48B
+20.5%
Inventory
$25.99B
+16.1%
Long Term Debt
$1.13B
-52.7%
Short Term Debt
$1.25B
-14.9%
Return on Assets
5.22%
N/A
Return on Invested Capital
5.66%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A